BioLineRx Ltd. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Modi In
SEC filing record 1 source field available
Fiscal year end
31 December
BioLineRx Ltd. has filed 612 SEC EDGAR filings since 24 Sep 2010

SEC filing history

Showing 251-275 of 612 matching filings.

Per page
25
Current page
11
6-K File 001-35223

6-K

Filing date
01 Aug 2018
Reporting date
01 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
30 Jul 2018
Reporting date
30 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
18 Jun 2018
Reporting date
18 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
22 May 2018
Reporting date
22 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
17 May 2018
Reporting date
17 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
17 May 2018
Reporting date
17 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
16 May 2018
Reporting date
16 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
24 Apr 2018
Reporting date
24 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
16 Apr 2018
Reporting date
16 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-35223

CT ORDER filing

Filing date
02 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
26 Mar 2018
Reporting date
26 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
12 Mar 2018
Reporting date
12 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
06 Mar 2018
Reporting date
06 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
27 Feb 2018
Reporting date
27 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86614

BIOLINERX LTD.

Filing date
12 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
23 Jan 2018
Reporting date
23 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
23 Jan 2018
Reporting date
23 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-222332

EFFECT filing

Filing date
19 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
19 Jan 2018
Reporting date
19 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-222332

424B5

Filing date
19 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-3/A File 333-222332

F-3/A

Filing date
19 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
18 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
17 Jan 2018
Reporting date
17 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
09 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .